0 Table of Contents |
1 Home |
2 Home (en) |
3 Architektur |
4 Architecture |
5 Dateiformate |
6 File Formats |
7 Quickstart (de) |
8 Quickstart (en) |
9 Setup (de) |
10 Setup (en) |
11 Support (de) |
12 Support (en) |
13 Technische Dokumentation |
14 Technical Documentation |
15 UI Features (de) |
16 UI Features (en) |
17 Wie man TerminoloGit verwendet |
18 How to use TerminoloGit |
19 Artifacts Summary |
19.1 APPC_Anatomie |
19.2 APPC_Lateralitaet |
19.3 APPC_Modalitaet |
19.4 APPC_Prozeduren |
19.5 atcdabbr-LateralityQualifiercode |
19.6 atcdabbr_NoInformationQualifier |
19.7 Austrian Designation Use |
19.8 DGC_Country |
19.9 DGC_DiseaseOrAgent |
19.10 DGC_Doses |
19.11 DGC_MedicinalProduct |
19.12 DGC_RATNameManufacturer |
19.13 DGC_ResultOfTheTest |
19.14 DGC_TypeofTest |
19.15 DGC_Vaccine |
19.16 DGC_VaccineMarketingAuthorizationHolder |
19.17 DICOM_SOPClasses |
19.18 eHDSI-Administrative-Gender |
19.19 eHDSI-Country |
19.20 eHDSI-DoseForm |
19.21 eHDSI-HealthcareProfessionalRole |
19.22 eHDSI-Package |
19.23 eHDSI-Quantity-Unit |
19.24 eHDSI-Route-of-Administration |
19.25 eHDSI-Substance |
19.26 eHDSI-Telecom-Address |
19.27 eHDSI-Timing-Event |
19.28 eHDSI-Unit |
19.29 eHDSI_ActiveIngredient |
19.30 eHDSI_ActSubstanceAdministrationCode |
19.31 EHDSI_Confidentiality |
19.32 EHDSI_Language |
19.33 eImpf_Antikoerperbestimmung |
19.34 eImpf_HistorischeImpfstoffe |
19.35 eImpf_ImmunizationTarget |
19.36 eImpf_Impfdosis |
19.37 eImpf_Impfgrund |
19.38 eImpf_ImpfrelevanteErkrankung |
19.39 eImpf_Impfrollen |
19.40 eImpf_Impfschema |
19.41 eImpf_Impfstoffe |
19.42 eImpf_Mengenart |
19.43 eImpf_SpecialCaseVaccination |
19.44 eImpf_SpecialSituationIndication |
19.45 eImpf_Zusatzklassifikation |
19.46 eImpf_Zusatzklassifikation_Impfprogramm |
19.47 eImpf_Zusatzklassifikation_Impfsetting |
19.48 ELGA Lebensmittelallergene |
19.49 ELGA_AbsentOrUnknownAllergies |
19.50 ELGA_AbsentOrUnknownDevices |
19.51 ELGA_AbsentOrUnknownMedication |
19.52 ELGA_AbsentOrUnknownProblems |
19.53 ELGA_AbsentOrUnknownProcedures |
19.54 ELGA_ActCode_AbgInfo |
19.55 ELGA_ActCode_PatInfo |
19.56 ELGA_ActEncounterCode |
19.57 ELGA_AddressUse |
19.58 ELGA_AdministrativeGender |
19.59 ELGA_AlcoholConsumption |
19.60 ELGA_AllergieTyp |
19.61 ELGA_AllergyOrIntoleranceAgent |
19.62 ELGA_AllergyOrIntoleranceType |
19.63 ELGA_AllergyReaction |
19.64 ELGA_AllergyStatusCode |
19.65 ELGA_AnamneseLaborMikrobiologie |
19.66 ELGA_Antibiogramm |
19.67 ELGA_ArtderDiagnose |
19.68 ELGA_AuditEventID |
19.69 ELGA_AuditEventType |
19.70 ELGA_AuditEventType_A-ARR |
19.71 ELGA_AuditParticipantObjectIdType |
19.72 ELGA_AuditParticipantObjectType |
19.73 ELGA_AuditParticipantObjectTypeRole |
19.74 ELGA_AuditRoleID |
19.75 ELGA_AuditSourceType |
19.76 ELGA_AuthorSpeciality |
19.77 ELGA_ConditionStatusCode |
19.78 ELGA_ConditionVerificationStatus |
19.79 ELGA_Confidentiality |
19.80 ELGA_CriticalityObservationValue |
19.81 ELGA_CurrentSmokingStatus |
19.82 ELGA_Diagnosesicherheit |
19.83 ELGA_Dokumentenklassen |
19.84 ELGA_Dosisparameter |
19.85 ELGA_Einnahmezeitpunkte |
19.86 ELGA_EntityNamePartQualifier |
19.87 ELGA_EntityNameUse |
19.88 ELGA_EntlassungsmanagementA |
19.89 ELGA_ExpectedDeliveryDateMethod |
19.90 ELGA_FormatCode |
19.91 ELGA_FormatCodeZusatz |
19.92 ELGA_HealthcareFacilityTypeCode |
19.93 ELGA_HumanActSite |
19.94 ELGA_HumanLanguage |
19.95 ELGA_InformationRecipientType |
19.96 ELGA_InsuredAssocEntity |
19.97 ELGA_KulturErregernachweis |
19.98 ELGA_Laborparameter |
19.99 ELGA_Laborstruktur |
19.100 ELGA_Laendercodes |
19.101 ELGA_LanguageAbilityMode |
19.102 ELGA_LanguageCode |
19.103 ELGA_MammogramAssessment |
19.104 ELGA_MaritalStatus |
19.105 ELGA_MedicalDevices |
19.106 ELGA_Medientyp |
19.107 ELGA_MedikationAbgabeArt |
19.108 ELGA_MedikationArtAnwendung |
19.109 ELGA_MedikationDarreichungsform |
19.110 ELGA_MedikationFrequenz |
19.111 ELGA_MedikationMengenart |
19.112 ELGA_MedikationMengenartAlternativ |
19.113 ELGA_MedikationPharmazeutischeEmpfehlungStatus |
19.114 ELGA_MedikationRezeptart |
19.115 ELGA_MedikationRezeptpflichtstatus |
19.116 ELGA_MedikationTherapieArt |
19.117 ELGA_Mikroorganismen |
19.118 ELGA_NachweisErgebnis |
19.119 ELGA_NoInformation |
19.120 ELGA_NullFlavor |
19.121 ELGA_ObservationInterpretation |
19.122 ELGA_ParticipationFunctionCode |
19.123 ELGA_PersonalRelationship |
19.124 ELGA_PracticeSetting |
19.125 ELGA_PregnanciesSummary |
19.126 ELGA_PregnancyStatus |
19.127 ELGA_Probenmaterial |
19.128 ELGA_Problemarten |
19.129 ELGA_Problemkataloge |
19.130 ELGA_ProblemSeverity |
19.131 ELGA_ProblemStatusCode |
19.132 ELGA_ProcedureApproachSite |
19.133 ELGA_ProficiencyLevelCode |
19.134 ELGA_RealmCode |
19.135 ELGA_ReligiousAffiliation |
19.136 ELGA_RoleClass |
19.137 ELGA_Rollen |
19.138 ELGA_SectionsEntlassungAerztl |
19.139 ELGA_SectionsEntlassungPflege |
19.140 ELGA_SectionsPflegeSitber |
19.141 ELGA_SectionsRadiologie |
19.142 ELGA_SectionsServiceEvents |
19.143 ELGA_Seitenlokalisation |
19.144 ELGA_ServiceEventPerformer |
19.145 ELGA_ServiceEventsEntlassbr |
19.146 ELGA_ServiceEventsLabor |
19.147 ELGA_ServiceEventsTelemonEpi |
19.148 ELGA_SignificantPathogens |
19.149 ELGA_SpecimenType |
19.150 ELGA_TargetSite |
19.151 ELGA_TelecomAddressUse |
19.152 ELGA_TopographicalModifierQualifier |
19.153 ELGA_TypeOfProblem |
19.154 ELGA_URLScheme |
19.155 ELGA_Vitalparameterarten |
19.156 ELGA_Wirkstoffe_AGES |
19.157 EMS_Anti-HCV-Immunoassay |
19.158 EMS_Anti-HCV-Immunoblot_Assay |
19.159 EMS_Betreuung |
19.160 EMS_HBV_Status |
19.161 EMS_HCV_core_Ag_Assay |
19.162 EMS_Hospitalisierung |
19.163 EMS_Impfstatus |
19.164 EMS_KlinischeManifestation |
19.165 EMS_Krankheitsmerkmale |
19.166 EMS_LebensmittelbedingteIntoxikationen |
19.167 EMS_MaterialMethode |
19.168 EMS_Meldepflichtige_Krankheiten |
19.169 EMS_Reiseland |
19.170 EMS_Taetigkeitsbereich |
19.171 EntityCode |
19.172 HL7-at_ActConsentType |
19.173 HL7-at_AdministrativeGender-FHIR-Extension |
19.174 HL7-at_AdministrativeGender-v2 |
19.175 HL7-at_OrganizationType |
19.176 HL7-at_PatientIdentifier |
19.177 HL7-at_PractitionerRole |
19.178 HL7-at_XDS-Dokumentenklassen |
19.179 langid-at |
19.180 LKF_Diagnose-Art |
19.181 LKF_Diagnose-statAuf |
19.182 LKF_Diagnose-Typ |
19.183 Orphanet_Rare Diseases |
19.184 ParticipationType |
19.185 RouteOfAdministration |
19.186 SNOMED_Rare Diseases |
19.187 TargetAwareness |
19.188 Zeiteinheiten |
19.189 APPC_Anatomie |
19.190 APPC_Lateralitaet |
19.191 APPC_Modalitaet |
19.192 APPC_Prozeduren |
19.193 ASP-Liste |
19.194 ATC deutsch (WIdO) |
19.195 Austrian Designation Use |
19.196 BMG Leistungskatalog Gesamt 2023 |
19.197 BMG Leistungskatalog Gesamt 2024 |
19.198 DCM |
19.199 DGC_Antibody-Test |
19.200 DGC_QR |
19.201 DGC_RATNameManufacturer |
19.202 DICOM_SOPClasses |
19.203 eHDSI-Substance |
19.204 eHDSI_EDQM_Auszug |
19.205 EHDSI_Language |
19.206 eImpf_Ergaenzung |
19.207 eImpf_HistorischeImpfstoffe |
19.208 eImpf_Impfstoffe |
19.209 eImpf_Schemamatrix |
19.210 eImpf_Zuordnungsmatrix |
19.211 ELGA-Lebensmittelallergene |
19.212 ELGA_ActCode |
19.213 ELGA_AllergieTyp |
19.214 ELGA_AuditEventID |
19.215 ELGA_AuditEventType |
19.216 ELGA_AuditEventTypeA-ARR |
19.217 ELGA_AuditParticipantObjectIdType |
19.218 ELGA_AuditParticipantObjectType |
19.219 ELGA_AuditParticipantObjectTypeRole |
19.220 ELGA_AuditSourceType |
19.221 ELGA_e-Health_Anwendungen |
19.222 ELGA_EntlassungsmanagementArt |
19.223 ELGA_Ergaenzungsliste |
19.224 ELGA_Fachaerzte |
19.225 ELGA_FormatCode |
19.226 ELGA_FormatCodeZusatz |
19.227 ELGA_Funktionsrollen |
19.228 ELGA_GDA_Aggregatrollen |
19.229 ELGA_GTelVoGDARollen |
19.230 ELGA_Kontakttypen |
19.231 ELGA_LaborparameterErgaenzung |
19.232 ELGA_MammogramAssessment |
19.233 ELGA_MedikationMengenartAlternativ |
19.234 ELGA_Patienten-Identifizierungsmethoden |
19.235 ELGA_Pflegestufen |
19.236 ELGA_PracticeSetting |
19.237 ELGA_Sections |
19.238 ELGA_ServiceEventsEntlassbrief |
19.239 ELGA_SignificantPathogens |
19.240 ELGA_SpecimenType_Ergaenzung |
19.241 ELGA_URLSchemeErgaenzung |
19.242 EMS_Analysedetails |
19.243 EMS_AntigenH |
19.244 EMS_AntigenO |
19.245 EMS_ArtMalaria |
19.246 EMS_ArtQuartier |
19.247 EMS_Aviditaet |
19.248 EMS_Befundart |
19.249 EMS_Betreuung |
19.250 EMS_Biotyp_Biovar |
19.251 EMS_Durchgefuehrt |
19.252 EMS_ErgaenzungMeldepflichtigeKrankheiten |
19.253 EMS_Ergebnis |
19.254 EMS_Genogruppe |
19.255 EMS_Genotyp |
19.256 EMS_GenotypPorA_R1 |
19.257 EMS_GenotypPorA_R2 |
19.258 EMS_Gewinnung |
19.259 EMS_HCV_RNA |
19.260 EMS_JaNein |
19.261 EMS_KlinischeManifestation |
19.262 EMS_Krankheitsmerkmale |
19.263 EMS_ListeSchulen |
19.264 EMS_Material |
19.265 EMS_MaterialMethode |
19.266 EMS_Methoden |
19.267 EMS_MonoclonalSub |
19.268 EMS_MultiLocSequ |
19.269 EMS_Nachweis |
19.270 EMS_Nachweisbar |
19.271 EMS_Organ |
19.272 EMS_OrtH20Probe |
19.273 EMS_Parameter |
19.274 EMS_Phagentyp |
19.275 EMS_Phagentyp_VTEC |
19.276 EMS_PosNeg |
19.277 EMS_Quartiercode |
19.278 EMS_Reiseland |
19.279 EMS_Ribotype |
19.280 EMS_Serogruppe |
19.281 EMS_Serotyp |
19.282 EMS_Serotyp_Gene_FetA |
19.283 EMS_TBC_ResistenzErgaenzung |
19.284 EMS_TBC_Resultat |
19.285 EMS_TBC_Typ |
19.286 EMS_TestMethodeMIC_IPD |
19.287 EMS_TestMethodeTypingIPD |
19.288 EMS_Verotoxin_1_Subtyp |
19.289 EMS_Verotoxin_2_Subtyp |
19.290 EMS_WoWurdeKrankheitErworben |
19.291 EMS_WurdeKrankheitImportiert |
19.292 EMS_YersinaPathogen |
19.293 EXNDS_Concepts |
19.294 EXNDS_FormatCodes |
19.295 EXNDS_Metadaten |
19.296 EXNDS_Sections |
19.297 GDA-Org |
19.298 GDA_Attribute |
19.299 Geschlechtercodes - ISO IEC 5218 |
19.300 HL7 Act Code |
19.301 HL7 Act Site |
19.302 HL7 ActStatus |
19.303 HL7 Address Use |
19.304 HL7 Administrative Gender |
19.305 HL7 Administrative Sex |
19.306 HL7 AT FormatCodes |
19.307 HL7 AT ReligionAustria |
19.308 HL7 Confidentiality Code |
19.309 HL7 Consent Mode |
19.310 HL7 Consent Status |
19.311 HL7 Consent Type |
19.312 HL7 Entity Name Part Qualifier |
19.313 HL7 Entity Name Use |
19.314 HL7 Konformitaet |
19.315 HL7 Language Identification |
19.316 HL7 LanguageAbilityMode |
19.317 HL7 Marital Status |
19.318 HL7 Null Flavor |
19.319 HL7 Observation Interpretation |
19.320 HL7 Participation Function |
19.321 HL7 Participation Type |
19.322 HL7 ProficiencyLevelCode |
19.323 HL7 Role Class |
19.324 HL7 Role Code |
19.325 HL7 Signatory's Relationship to Subject |
19.326 HL7 Specimen Type |
19.327 HL7 Timing Event |
19.328 HL7 URLScheme |
19.329 HL7-at_AdministrativeGender-Ergaenzung |
19.330 IANA Mime Type |
19.331 ICD-10 BMG 2014 |
19.332 ICD-10 BMG 2017 |
19.333 ICD-10 BMG 2020 |
19.334 ICD-10 BMSGPK 2022 |
19.335 ICD-10 BMSGPK 2024+ |
19.336 ICD-O-3 |
19.337 ICF |
19.338 ICPC2 |
19.339 IHE Pharmaceutical Advice Status List |
19.340 IPS_AbsentOrUnknownData |
19.341 IPS_ConditionClinicalStatusCodes |
19.342 IPS_ConditionVerificationStatus |
19.343 ISCO |
19.344 ISO 3166 Alpha-2-Code |
19.345 ISO 3166-1 alpha 3 |
19.346 ISO 639-2 |
19.347 Leistungskatalog Ambulant |
19.348 Leistungskatalog Gesamt |
19.349 Leistungskatalog Stationaer |
19.350 LKF_Diagnose-Art |
19.351 LKF_Diagnose-statAuf |
19.352 LKF_Diagnose-Typ |
19.353 LKF_Ergaenzung |
19.354 MDC_MedicalDeviceCommunications |
19.355 MedikationRezeptart |
19.356 MedikationTherapieart |
19.357 Medikation_ActiveIngredient |
19.358 Medikation_AGES_Wirkstoffe |
19.359 Medikation_Art_Anwendung |
19.360 Medikation_Darreichungsform |
19.361 Medikation_Packaging |
19.362 Medikation_Rezeptpflichtstatus |
19.363 OEAEK_Additivfach |
19.364 OEAEK_Berechtigungen |
19.365 OEAEK_Fachrichtung |
19.366 OEAEK_Spezialdiplom |
19.367 OEAEK_Spezialisierung |
19.368 OEAEK_Zertifikate |
19.369 RAST-Klassen |
19.370 Sciphox Diagnosenzusatz |
19.371 Sciphox_Seitenlokalisation |
19.372 SNOMED CT (Auszug) |
19.373 UCUM |
19.374 ELGA Lebensmittelallergene Mapping |
19.375 SNOMED Orphanet Mapping |